|
|
7752 Primrose Lane Portage, MI 49024 USA phone: fax:
|
|
| Symbol |
|
| Exchange |
|
| Founded |
0 |
| Employees |
|
|
|
| www.eadevices.com
|
|
| Research Sector |
Medical Devices & Tech |
|
 |
| Summary Description |
| EADevices works in the research and development of energy-assisted biopsy devices.
|
 |
| Management |
| Joshua Gerlick- CEO, Dr. Peter C. Johnson- President, Patrick Morand- Managing Director SWMF Life Science Fund
|
| |
|
|
|
|
|
| Keywords |
| Equipment and Devices, Surgical Equipment & Minimally or Less Invasive Devices. |
|
|
|
| Description |
|
EADevices works in the research and development of energy-assisted biopsy devices.
|
 |
| Products / Services |
EANeedle- Designed for bone marrow biopsy and intraosseous infusion procedures.
The EANeedle- Utilizes a novel disposable tissue chamber and needle combination that allows energy assistance to provide for a clean core sample of tissue, without the concern of "dry taps," which would normally require a reinsertion of the needle.
|
 |
| Technology / Differentiation |
| The greatest advantage of EADevices' technology is the elimination of the strong pushing force normally required to penetrate tissue, which often leads to intense patient anxiety and operator fatigue. |
 |
| Market / Customers |
Congress passed the Needlestick Safety and Prevention Act (HR 5178) in 2000, mandating that healthcare facilities eliminate the use of "sharp" devices when possible. Reacting to this critical demand, a $693 million annual market was created.
|
 |
| Status |
| EADevices was named one of ten "Rising Star" finalists in the 2004 Pittsburgh Technology Council's Tech 50 Awards.
|
 |
|
|
|
|
|
|